AECOPD I prescription

AECOPD I prescription is a Traditional Chinese Medicine (TCM) formulation developed by the GuiZhou University of Traditional Chinese Medicine for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). As a multi-herb prescription, it is designed to address the complex pathophysiology of COPD flare-ups, which typically involve increased airway inflammation, mucus hypersecretion, and bronchoconstriction. The formulation is currently being investigated in clinical trials to evaluate its efficacy in reducing symptoms and improving clinical outcomes in patients hospitalized or treated for acute exacerbations. TCM prescriptions of this nature typically aim to regulate the immune response and improve respiratory function through the synergistic effects of various botanical compounds.